CCR1 antagonists and methods of use therefor

摘要

The invention provides compounds having the formula: wherein R<1 >is halogen. The invention also provides compositions comprising the compounds, and methods of treating diseases or disorders that comprise administering one or more of the compounds to a subject in need thereof. The disclosed compounds have CCR1 antagonist activity.